CASI Competitors & Alternatives
Compare CASI Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
CASI
Main Stock$0.21
-74.06%
Tradestie Score
42
Market Cap
$26.18M
Revenue Growth
-60.5%
Analyst Upside
+1827.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Drug Discovery Biotech
Drug Design
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRZN
Surrozen, Inc. Common
|
$28.46
-7.21%
|
$117.07M | - | 34 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.37
-4.30%
|
$110.20M | - | 44 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.31
+0.76%
|
$84.52M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$6.96
-1.14%
|
$67.94M | - | 48 | Compare |
|
CLSD
Clearside Biomedical, Inc. Common Stock
|
$0.41
-26.96%
|
$21.88M | - | 42 | Compare |
|
APTO
APTO
|
- | - | - | - | Compare |
|
OPGN
OPGN
|
- | - | - | - | Compare |
|
ENG
ENG
|
- | - | - | - | Compare |
|
MEIP
MEIP
|
- | - | - | 49 | Compare |
|
BGNE
BGNE
|
- | - | - | - | Compare |
More CASI Analysis
Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry